8-K
filed December 16, 2022, 6:59 PM ET
ticker OGEN
CIK 0001174940
leadership
confidence high
sentiment negative
materiality 0.70
Oragenics CFO resigns; CEO assumes interim role; shareholders reject authorized share increase
ORAGENICS INC
- Michael Sullivan resigned as CFO, Secretary, and Treasurer effective December 14, 2022.
- CEO Kimberly Murphy appointed as Interim CFO, Secretary, and Treasurer effective December 15, 2022.
- Sullivan will remain as consultant from December 15, 2022 through January 31, 2023 for transition.
- At 2021 Annual Meeting on December 16, 2022, all five director nominees were re-elected.
- Proposal to increase authorized common shares from 250M to 350M failed; 34.8M for, 9.0M against, 0.8M abstain.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kimberly Murphy was appointed as Interim Chief Financial Officer, Secretary and Treasurer at ORAGENICS INC.
- Action
- appointed
- Role
- Interim Chief Financial Officer, Secretary and Treasurer
Exact text from the filing
Effective December 15, 2022, Ms. Kimberly Murphy, the Company’s President and Chief Executive Officer, was appointed Interim Chief Financial Officer, Secretary and Treasurer of the Company
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Sullivan resigned as Chief Financial Officer, Secretary and Treasurer at ORAGENICS INC.
- Action
- resigned
- Role
- Chief Financial Officer, Secretary and Treasurer
Exact text from the filing
Michael Sullivan’s resignation as Chief Financial Officer, Secretary and Treasurer of the Company, to be effective December 14, 2022
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORAGENICS INC shareholders approved Election of Directors at the 2022-12-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-12-16
Exact text from the filing
PROPOSAL I: Election of Directors. Ms. Kim Murphy, Dr. Frederick Telling, Mr. Robert Koski, Mr. Charles Pope and Dr. Alan Dunton were each re-elected as Directors, to serve until our next annual meeting of shareholders or until their respective successors are elected and qualified or until their earlier resignation, removal from office or death. The votes were as follows: For Withheld Broker Non-Votes Kim Murphy 22,475,527 1,632,823 20,557,696 Dr. Frederick Telling 20,922,955 3,185,395 20,557,696 Robert Koski 22,435,114 1,673,236 20,557,696 Charles Pope 22,046,998 2,061,352 20,557,696 Dr. Alan Dunton 22,239,159 1,869,191 20,557,696
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORAGENICS INC shareholders rejected To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation which will increase the number of authorized shares of our Common Stock from 250,000,000 shares of Common Stock to 350,000,000 shares of Common Stock at the 2022-12-16 meeting.
- Proposal
- charter amendment
- Outcome
- failed
- Meeting
- 2022-12-16
Exact text from the filing
PROPOSAL III: To approve the adoption of an amendment to our Amended and Restated Articles of Incorporation which will increase the number of authorized shares of our Common Stock from 250,000,000 shares of Common Stock to 350,000,000 shares of Common Stock. The votes were as follows: FOR 34,818,848 AGAINST 9,032,041 ABSTAIN 815,157
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORAGENICS INC shareholders approved Ratification of the selection of Mayer Hoffman McCann P.C. as the Company's independent auditors for the year ending December 31, 2022 at the 2022-12-16 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-12-16
Exact text from the filing
PROPOSAL IV: Ratification of the selection of Mayer Hoffman McCann P.C. as the Company's independent auditors for the year ending December 31, 2022. The votes were as follows: FOR 41,807,116 AGAINST 1,929,362 ABSTAIN 929,568
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORAGENICS INC shareholders approved To conduct a non-binding advisory vote on executive compensation at the 2022-12-16 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2022-12-16
Exact text from the filing
PROPOSAL II: To conduct a non-binding advisory vote on executive compensation. The votes were as follows: FOR 18,984,656 AGAINST 4,363,215 ABSTAIN 760,479 BROKER NON-VOTES 20,557,696
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.